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.2013.01.Abstract Background: Monitored anesthesia care (MAC) has been proposed as one of the suit-
able techniques for rhinoplasty. In this study our aim was to compare the effects of dexmedetom-
idine with morphine and propofol vs benzodiazepines with morphine and propofol as adjuncts to
local anesthesia – on analgesia, sedation, respiratory and hemodynamics variables and surgeon and
patient satisfaction.
Methods: In this prospective, double-blind, comparative study, 60 patients undergoing rhinoplasty
by local anesthesia randomly received intravenous sedation of either: dexmedetomidine (Dex group)
or midazolam (Mid group) in combination with morphine and propofol. Level of sedation was
assessed by using the Observer’s Assessment Alertness/Sedation Scale (OAA/S). Pain on local anes-
thesia injection was assessed by a visual analog scale. Surgeon’s satisfaction also can be assessed by
using a 3-grades score, the surgeon assessed the quality of surgical bleeding. Mean Arterial Pressure
(MAP) and heart rate (HR) were assessed and recorded. Patients’ satisfaction, visual analog scale
for intraoperative pain, and total amount of propofol used intraoperatively. Adverse effects were
also recorded.
Results: In Mid group patients were earlier to reach adequate sedation level than in Dex group, but
they felt more pain either on local anesthetic injection or during operation. Intraoperative mean966507200280; fax: +20
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182 A. Ragab et al.arterial blood pressure and heart rate in Dex group were lower than their baseline values and the
corresponding values in Mid group. The total amount of propofol needed for Mid group was much
higher than in Dex group. Patient satisfaction was higher in Dex group. Time of surgery was longer
in Mid group. Both groups were similar in sedation recovery and ward discharge times, as well as,
incidence of side effects.
Conclusion: Dexmedetomidine sedation with morphine and propofol in rhinoplasty performed
under local anesthesia was associated with shorter surgery time, greater patient and surgeon satis-
faction, and lower pain scores with no adverse effects, when compared to midazolam sedation with
morphine and propofol.
ª 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Nowadays, rhinoplasty is one of the most common plastic sur-
gery. It can be done to reduce the size of the nose, to change
the shape of the tip or nasal bridge, to narrow the opening
of the nostrils or all of them [1–3].
According to the exact procedure done and the patient’s
preference rhinoplasty can be performed under local or general
anesthesia. Under local anesthesia patients can be kept asleep
(conscious sedation) or awake as desired [4,5].
It may be performed either in a hospital, or an outpatient
surgery center [5]. Local anesthesia provides improvement of
pain relief, shorter hospital stay, decreased postoperative opi-
oid use, and decreases the incidence of postoperative nausea
and vomiting (PONV), time spent in recovery room, and im-
proved patient satisfaction with similar operating conditions
comparable to general anesthesia [5,6].
The use of sedative drugs with local anesthesia in rhino-
plasty has not been studied well, we found only one article
was done by Einstein [7] for cosmetic nose surgery without
intubation, the patient is fully monitored for respiratory, heart
and cognitive function. The propofol is continuously adjusted
with the aid of a computerized pump. He found that, propofol
was enough medication was given to eliminate the discomfort
of the local anesthesia injections [7].
Dexmedetomidine is a highly selective 2-agonist with sed-
ative, sympatholytic, and analgesic-sparing properties, with a
favorable safety proﬁle and little effect on respiration com-
pared with benzodiazepines and propofol [8].
Additionally, dexmedetomidine decreases salivary secre-
tion, through sympatholytic and vagomimetic effects [9].
Small-dose infusion of this drug in healthy volunteers provides
sedation that can be easily reversed with verbal stimuli [10].
This randomized, double-blind, clinical study was designed
to compare the sedative, respiratory and hemodynamic effects
together with patients’ and surgeon’s satisfaction of dexmede-
tomidine and benzodiazepines in combination with morphine
and propofol during rhinoplasty under local anesthesia.2. Patients and methods
After approval of the ethical committee in New Jeddah Clinic
Hospital (Saudi Arabia), a written informed consent obtained
from a sixty patients of ASA physical status I and II, aged 18–
50 years old, who were scheduled for elective rhinoplasty, were
enrolled in this randomized, double-blind, clinical study.
Exclusion criteria were age <18 years, a history of drug oralcohol abuse, chronic use of drugs known to alter the anes-
thetic or analgesic requirements(psycho stimulant drugs, Nefo-
pam), allergy to any of the study medications, second- or third-
degree heart block, chronic use of any 2-agonists, and a cur-
rent psychiatric or respiratory disorder. Obese patients with
BMI (body mass index)P 30 were also excluded. The local
anesthesia procedure was explained to the patient at his con-
sultation visit in anesthesia clinic. Patient selection is impor-
tant, the patient should be cooperative, understanding and
willing for local anesthesia.
On arrival in the operative theater and after the placement
of an IV catheter, a baseline measurement of respiratory rate
(RR), heart rate (HR), noninvasive mean arterial blood pres-
sure (MAP), and oxygen saturation (SpO2) were obtained (Da-
tex-Ohmeda; Aisys (GE healthcare). Sedation level was
assessed by using the Observer’s Assessment Alertness/Seda-
tion Scale (OAA/S) [11], scale: 5 = responds readily to name
spoken in normal tone (awake/alert), 4 = lethargic response
to name spoken in normal tone, 3 = responds only after name
spoken loudly or repeatedly, 2 = responds after mild prodding
or shaking and 1 = does not respond to mild prodding or
shaking (asleep/unarousable) [11].
Patients were asked to rate the VRS (Verbal Rating Scale;
0 = no pain, 10 = maximal pain). The OAA/S and VAS
scores were evaluated by an observer blinded to the patient’s
group. Patient satisfaction was assessed at the end of the pro-
cedure and after 15 min. in the recovery room. Surgeon’s sat-
isfaction was assessed and recorded at the end of the
procedure.
A nasal oxygen cannula was applied to the mouth and ﬁxed
in the chin by tap to supply O2 at ﬂow rate 3 L/min. Anesthesia
was started by Xylocaine spray 4% two puffs in each nostril
then wait for three minutes.
A light nasal pack soaked with Xylocaine gel and 5cc Xylo-
caine 2% with 1:100,000 Adrenaline was used to pack the nasal
cavity in a way as to cover the regions of the sphenopalatine
ganglion posteriorly, anterior ethmoid nerves under the nasal
bones and the pack is made in layers to cover as much of
the septum and inferior turbinates. Each pack is sutured to a
long silk tie, the tie is ﬁxed with plaster to the cheek.
At this point, patients were randomly assigned by a con-
cealed envelope method into one of two groups (each group
was 30 patients); Midazolam (Mid) group, received 0.07 mg/
kg Intravenously (total dose not more than 5 mg) of midazo-
lam (Dormicum, Fhoffmann-LaRoche Ltd, Switzerland).
The other group is dexmedetomidine (Dex) group (Precedex,
Abbott Laboratories Inc., Abbott Park, IL) (supplied in 2-ml
ampoules at a concentration of 100 lg /ml) received 0.75 lg/
Figure 2 This diagram shows the sites of injection for nasal
block (11 points technique).
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medetomidine for each patient was prepared in a total volume
of 20 ml normal saline and was infused over a period of
10 min. After injection of the study drugs, morphine 0.05–
0.1 mg/kg was injected to achieve good analgesia. Patients
were assessed for level of sedation using Observer’s Assessment
Alertness/Sedation Scale (OAA/S) and any patient having a
score > 4 received IV propofol 2–4 mg/kg/h very slowly until
the score 6 4.
For both groups local anesthesia started by injection of
lidocaine 2% with 1:200,000 Epinephrine in 10cc syringe and
27 gauge needles is used. Our aim is to eliminate pain and to
achieve vasoconstriction, Fig. 1.
In this study, our own technique for nasal block and we
named it 11 points technique: 3 single (midline injection) and
4 paired (bilateral injection) sites for injection, Fig. 2. A series
of Bolus injections and inﬁltration are administered (0.5–
1.00 ml for each point).
The three single midline injection points are: 1-the nasal tip.
2-subdermal plane in the midline of the columella from tip-
deﬁning points to the nasal spine. 3-the mid-point between
the two eye brows.
The four paired injection points are: 4 and 5-Bolus to the
alar base at the nasolabial junction. 6 and 7-Bolus at the fren-
ulum at the midpoint between ala and base of the septum. 8
and 9-Infraorbital nerve block by advance the needle through
the nasal ala to the site of the nerve, 10–11 Submucously, high
under the nasal bones to the region of the anterior ethmoid
nerve. Inﬁltrating along the nasofacial junction. The entry site
is intranasally at the pyriform aperture, then the needle is
pushed to a midpoint between the medial canthus and the na-
sion, then pulled while inﬁltrating. Care should be taken not to
enter the angular vein [12].
After 10 min of injection of local anesthesia most of the pa-
tients were lethargic and responded to name spoken in normal
tone (OAA/SP 4). The procedure done while the patient was
lightly sedated and communicating with the surgeon.Figure 1 Anatomy of the face with the nerves should be blocked
[12].To achieve adequate sedation during the procedure, in irri-
table and anxious patients an infusion of propofol 2–
4 mg kg1 h1. If unwanted bradycardia (HR< 50), or hypo-
tension (MAP< 50) were recorded, 0.5 mg atropine was
administered, and 200 mL of 0.9% saline was infused, respec-
tively. If apnea (respiratory rate < 6/min) or desaturation
(SpO2 < 90%) occurred patient was encouraged to take deep
breath.
OAA/S score, the respiratory (RR and SpO2) and hemo-
dynamic variables (MAP and HR) were recorded at 5-min
intervals after the baseline measurements until the termina-
tion of the procedure. These baseline measurements were ob-
tained just before injection of the studying drug. The OAA/S
scores and hemodynamic and respiratory variables were re-
corded post-operative every 10 min for 1 h in PACU. The
VAS scores were recorded at 5-min intervals during the pro-
cedure at 10, 15, 20, 25, 30, and 35 min. Patients’ satisfaction
was recorded post-operatively for all patients. A question-
naire, to rate the overall pain experience for all patients
was done (0 = no pain; 1 = mild; 2 = moderate; or 3 =
severe) and their degree of overall satisfaction with the man-
agement of their pain (0, poor; 1, adequate; 2, good; or 3,
excellent) after the procedure. The incidence of nausea and
vomiting were also recorded.
After the end of surgery, a surgeon who was blinded to the
studying groups was asked to rate his satisfaction by two
parameters, the ﬁrst one was according to bleeding in the sur-
gical ﬁeld 3-grades score used by Nasreen et al. [13] by the end
of operation (Grade I: bloodless ﬁeld not hampering surgery,
Grade II: mild bleeding requiring occasional suctioning, and
Grade III: excessive bleeding hampering surgery despite suc-
tioning) [13].The second one was according to movement of
the patient and unavoidable talking.
3. Statistical analysis
A total sample size of 60 divided into two equal groups was
found to be sufﬁcient to conduct the study. SPSS (statistical
program for social science version 12) was used for statistical
analysis.
Table 1 Patient characteristics (mean + SD or n).
Dex group (n= 30) Mid group (n= 30)
Age (years) 25 ± 10.1 26.9 ± 9.3
Gender
Male 15 17
Female 15 13
Weight (kg) 53 ± 13.2 55.2 ± 9.3
Height (cm) 169 ± 8 170 ± 5
Duration from start of sedation to the end of local anesthesia injection (min) 25.14 ± 4.29 23.45 ± 5.13
Duration of surgery (min) 40.3 ± 5.96 47.61 ± 3.30
Data are expressed as mean ± SD.
Figure 3 Shows the mean values of hemoglobin oxygen saturation (SpO2), heart rate (HR), mean arterial blood pressure (MAP) and
respiratory rate (RR) determined over the course of the procedure (total 60 min).
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age within the same group. Demographics were compared with
t-test. The proportions of men/women, dose of propofol given
to achieve adequate sedation, nausea, vomiting, overall pain
experience scores 2 and 3, and overall satisfaction scores 0
and 1 of the study groups were compared with v2 test. RR,
SpO2, MAP, HR, and VAS were compared with repeated mea-
sures analysis of variance (ANOVA) with post hoc Tukey test.
OAA/S was analyzed with Friedman’s nonparametric repeated
measures ANOVA with post hoc Tukey test. A p value of
<0.05 was considered signiﬁcant.4. Results
Sixty patients were recruited for this study (30 in each group).
Two patients were excluded in the MID group from the study
and were shifted to general anesthesia with endotracheal intu-
bation due to poor tolerance to local anesthesia and too much
movement. There were no statistically signiﬁcant differences
between the two groups regarding to age, gender, height and
body weight, as well as duration of anesthesia and duration
of surgery (Table 1).
Table 3 Intraoperative and postoperative adverse effects.
Dex group
(n= 30)
Mid group
(n= 28)
Apnea (respiratory rate < 6) 1 (3.3%) 8 (28.5%)
Desaturation SpO2 < 90% 1 (3.3%) 9 (32.1%)
Nausea 0 0
Vomiting 0 0
Bradycardia (HR< 50) 48 ± 4.3 55 ± 2.3
Hypotension (MAP< 50) 55 ± 3.2 62 ± 1.4
Data were expressed as mean ± SD, or numbers (%).
Table 2 Patient satisfaction score, pain scores and total
propofol given.
Dex group (n= 30) Mid group (n= 28)
Onset of sedation 17.1 ± 4.54** 6.7 ± 2.64
Patient satisfaction score
Excellent 23 (76.6%)** 2 (7.1%)
Good 6 (20%) 6 (21.4%)
Fair 1 (3.3%) 14 (50%)*
Poor 0 (0%) 6 (21.4%)
VAS on LA injection 1.5 ± 0.25 3.6 ± 0.90**
VAS intraoperative 1 ± 0.21 2.9 ± 0.30**
Baseline OAA/S, n (%)
5 29 24
4 1 2
3 0 1
2 0 1
1 0 0
Total propofol given 80 mg 200 mg**
Surgeon’s satisfaction score
Grade I 20 (66.6%)** 3 (10.7%)
Grade II 9 (30%) 19 (63.3%)*
Grade III 1 (3.3%) 6 (21.4%)
Data were expressed as mean ± SD, or numbers (%).
* p< 0.05; statistically signiﬁcant.
** p< 0.01; statistically highly signiﬁcant.
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baseline at 5 min, while MAP started to be lower than the
baseline at 10 min from the start of sedation. This signiﬁcant
reduction in hemodynamics in Dex group continued till the
end of surgery and showed signiﬁcant difference from those
values recorded in Mid group that showed more stable hemo-
dynamics with little change from the baseline (p< 0.05)
(Fig. 3).
The respiratory variables (RR and SpO2) were different in
Dex group than in Mid group. RR and SpO2 were signiﬁcantly
lower in Mid group than Dex group started after the ﬁrst 5 min
of injection till the end of the procedure and it showed signif-
icant difference from those values recorded in Dex group
(p< 0.05) (Fig. 3).
Patients in Mid group felt more pain on local anesthesia
injection than those in Dex group (VAS: 3.6 ± 0.9 vs
1.5 ± 0.25, respectively). Also, intraoperative pain was more
in Mid group compared to Dex group (VAS: 2.9 ± 0.3 vs
1 ± 0.21, respectively) p< 0.001 (Table 2).
Total amount of propofol injected in Mid group during the
study was signiﬁcantly higher than in Dex group.
Patients, satisfaction was better in Dex group (Table 2).
The method of sedation was described as excellent in most
of patients in Dex group (76.6%) vs (7.1%) of patients in
Mid group (p< 0.001). Poor satisfaction was not reported
in Dex group, while reported in 26.6% of patients in Mid
group.
Patients in Mid group achieved adequate sedation level ear-
lier than those in Dex group (6.7 ± 2.64 vs 17.1 ± 4.54,
respectively), (p< 0.001) (Table 2).
The times taken for recovery from sedation and discharge
from PACU were equal in both groups (Table 2).
Comparing Dex group to Mid group regarding surgeon’s
satisfaction about surgical ﬁeld bleeding Grades I, II, and IIIwere 20 (66.6%) \\ vs 3 (10.7) with p< 0.001, 9 (30%) vs
19 (63.3%) \\ with p< 0.001 and 1 (3.3%) vs 6 (21.4%)
respectively (Table 2). According to these results, surgical ﬁeld
bleeding Grade I (no bleeding) was signiﬁcantly better in Dex
group compared to Mid group (p< 0.001) and in Grade II
(moderate bleeding was signiﬁcantly higher in Mid group than
in Dex group (p< 0.001).
The intraoperative and postoperative adverse effects were
reported in both groups but it was insigniﬁcant and easily
managed (Table 3).
5. Discussion
The primary outcome of this study was to compare VAS and
OAA/S between dexmedetomidine and midazolam in sedation
and analgesia in combination with morphine and propofol
during rhinoplasty under local anesthesia. The secondary out-
come was Respiratory and hemodynamic variables. RR was
more slowly and SpO2 was less with midazolam than dexmede-
tomidine. Study drugs were comparable with regard to seda-
tion, MAP, HR, overall pain experience and satisfaction
scores.
Our results demonstrated that Dex sedation for rhinoplasty
was associated with signiﬁcantly lower HR and MAP values
when compared to midazolam sedation. While midazolam
group was earlier to achieve sedation, Dex group was associ-
ated with less operation time, higher patient satisfaction, and
lower pain scores. Both methods of sedation were equal in
the incidence of adverse effects, time for sedation recovery
and PACU discharge.
Dexmedetomidine was used in many settings to provide
sedation for operations performed under local anesthesia.
For aesthetic facial surgery under local anesthesia, Taghinia
et al. [14] compared the addition of dexmedetomidine infusion
to the usual sedative protocol (propofol, midazolam, fentanyl,
and ketamine), and they reported lower blood pressure values.
They also found that dexmedetomidine improved the sedation
safety as evidenced by the reported fewer incidences of oxygen
desaturation, and the reduced need for the use of narcotics,
and antiemetics [14].
When dexmedetomidine was compared to midazolam to
provide monitored anesthesia care for cataract surgery, Alhas-
hemi [15] found signiﬁcantly better patient satisfaction scores
in Dex group. Although he reported lower HR and MAP val-
ues in Dex group, he did not ﬁnd any difference in the inci-
dence of hypotension, bradycardia or desaturation between
both groups [15].
In this study, we reported lower HR and MAP in Dex
group, which provide controlled hypotensive anesthesia for
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in this group than in Mid group.
Mizuno et al. [16] observed that sedation with intravenous
midazolam during upper gastrointestinal endoscopy was useful
to control the cardiovascular responses, and to induce amne-
sia. However, they suggested that decreases in the SpO2 should
be monitored carefully. In the midazolam group, they ob-
served apnea in one patient and decreased SpO2 in two pa-
tients. No deterioration in respiratory and cardiovascular
parameters was observed in the dexmedetomidine group and
this previous results match well with the results of our study.
A combination of propofol, meperidine/fentanyl and
midazolam was used in 100 adult patients by Cohen et al.
[17]. Their study showed that endoscopy could be performed
at a moderate level of sedation by combining a low dose of
propofol with a narcotic agent and/or benzodiazepine, and
that the use of a small dose of a narcotic agent and midazolam
in combination with propofol does not prolong patient recov-
ery. However, Vargo et al. [18] reported that propofol led to
signiﬁcantly improved recovery to baseline activity compared
with a combination of midazolam/meperidine. Additionally,
they discovered 54 episodes of apnea/disordered respiration
in 28 patients receiving a combination of midazolam/meperi-
dine (mean duration 70.8 s). This idea and the concept of Co-
hen et al. (to reduce the side effects of drugs by administration
of small doses of other drugs) and it was the same way of
thinking in this study.
Durmus et al. [19] reported that dexmedetomidine was
associated with less bleeding, lower anesthetic requirements,
and more hemodynamic stability in response to anesthesia
and surgery in patients undergoing septorhinoplasty and tym-
panoplasty under general anesthesia [19]. This previous results
match well with the results of our study and it was one of the
important points that augment the surgeon’s satisfaction but
they studied the hypotensive effect of dexmedetomidine with
general anesthesia. On the other hand, Dogan et al. [20]. eval-
uated the surgical bleeding in septoplasty operations, and
found that those performed under local anesthesia with Dex
sedation were associated with signiﬁcantly less bleeding when
compared to those performed under general anesthesia [20].
In this study, we observed that the sneezing episode during
nasal block which is common during injection of local anesthe-
sia in the nose was much lower in Dex group than in Mid
group. This observation may be due to the deep sedative and
analgesic action of dexmedetomidine or through its sympatho-
lytic and vagomimetic effects that will leads to decreases sali-
vary and nasal secretion [9].
Cooper et al. [22], he and his colleagues found in their
study. Dexmedetomidine-treated patients were signiﬁcantly
more satisﬁed with their anesthetic than patients in the Mid
group. Higher satisfaction scores for dexmedetomidine com-
pared with midazolam have been reported in other trials as
well. In addition, anesthesiologists indicated that the ease of
achieving and maintaining the targeted sedation level was sig-
niﬁcantly better in dexmedetomidine group compared with the
group using midazolam [21,22].
In another study, McCutcheon et al. [23] found that dex-
medetomidine, when compared with midazolam and fentanyl
in carotid surgery patients was associated with fewer interven-
tions for hypertension and tachycardia. The effect of reducing
HR and arterial blood pressure could be beneﬁcial for patients
at risk for cardiac morbidity because perioperative tachycardiaand hypertension are associated with adverse cardiac outcomes
in the postoperative period [24].
The use of sedative drugs with local anesthesia in rhino-
plasty has not been studied well, we found only one article
was done by Einstein [7] for cosmetic nose surgery without
intubation, the patient is fully monitored for respiratory, heart
and cognitive function. The propofol is continuously adjusted
with the aid of a computerized pump. He found that, propofol
was enough medication was given to eliminate the discomfort
of the local anesthesia injections [7].
In conclusion, dexmedetomidine with morphine and propo-
fol at the doses studied well-tolerated, safe with lower inci-
dence of clinically relevant respiratory depression, better
patient’s satisfaction and effective primary sedative alternative
to midazolam in patients undergoing MAC for rhinoplasty de-
spite a signiﬁcant lower mean arterial blood pressure and HR.References
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